SLC18A3 p.Pro144Ser
c.430C>T · VCV4631045
Computational evidence
| Protein change | ||
| AlphaMissense | 0.122 | likely benign |
|---|---|---|
| REVEL | 0.048 | moderately benign-leaning |
| SaProt | LLR -11.65 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 0.99 | GERP -1.5, phastCons 0.74 |
| Regional constraint | o/e 1.00 | unconstrained · MANE · 1,196 bp · p 0.99 · regional, not allelic |
| Overall | ||
| CADD | 16.33 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- SLC18A3
- Protein
- p.Pro144Ser
- Coding
- c.430C>T
- MANE Select
- NM_020549 · reported on NM_003055
- Type
- single nucleotide variant
- Location
- chr10:49611170 (GRCh38)
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/slc18a3-p-pro144ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown